MarketBeat on MSN20d
3 Stocks to Gain From Trump’s Family Caregiver Tax CreditsIn June 2023, Amedisys accepted the acquisition offer from UnitedHealth Group Inc. (NYSE: UNH) Optum Healthcare unit for $101 per share or $3.3 billion. This deal would further help transition ...
In June 2023, Amedisys accepted the acquisition offer from UnitedHealth Group Inc. (NYSE: UNH) Optum Healthcare unit for $101 per share or $3.3 billion. This deal would further help transition ...
Hackers stole sensitive information belonging to around 190 million people in a cyberattack on a UnitedHealth Group subsidiary last year that roiled the U.S. healthcare industry, the company said ...
For a more in-depth analysis of 2024 healthcare financial trends, find our full trends report here. Healthcare leaders enter 2025 facing a host of pressing imperatives. They need to promote ...
UnitedHealth Group has quietly but significantly scaled back its MedExpress urgent care business, with all locations now closed in Minnesota and just 19 operating across the country — down from ...
As criticism of the U.S. healthcare system continues to mount due to its high per capita costs, relatively poor population health outcomes (life expectancy, infant mortality, etc.), and restricted ...
Jan. 30, 2025 — A green alga that grows in lakes and rivers could be the next 'superfood' -- helping scientists to tackle global food security challenges while promoting environmental ...
Winchester, Va.-based Valley Health named Steve Motil as its new chief data and analytics officer. In this role, Mr. Motil will spearhead initiatives to make Valley Health more data-driven and ...
Feb. 17, 2025 — In a surprising discovery, scientists have found that the heart possesses 'sweet taste' receptors, similar to those on our tongues, and that stimulating these receptors with ...
Those Valentine flowers might come with a bit more than vivid colors and a nice scent More than 80 domestic cats have been confirmed to have had bird flu since 2022. Lawyers for South Carolina and ...
The U.S. Food and Drug Administration approved British drugmaker GSK's combination vaccine to protect against meningococcal infection for use in people aged 10 through 25 years, the company said ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results